Dendreon (DNDN) says FDA approved the rest of its New Jersey manufacturing sites, expanding the launch of Provenge
Tweet Send to a Friend
Dendreon (Nasdaq: DNDN) says the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
